1 / 10

Good Clinical Practice (GCP)- An introduction

Good Clinical Practice (GCP)- An introduction. Dr Noor Ibrahim Mohamed Sakian. Contents. Background What is GCP? History – International Committee on Harmonisation (ICH) of GCP Principles of ICH GCP GCP rules of conduct IRB/IEC Investigators responsibilities

berget
Download Presentation

Good Clinical Practice (GCP)- An introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian

  2. Contents • Background • What is GCP? • History – International Committee on Harmonisation (ICH) of GCP • Principles of ICH GCP • GCP rules of conduct • IRB/IEC • Investigators responsibilities • Sponsors responsibilities • Trial protocol • Investigator’s brochure • Essential documents

  3. Background • Academicians, clinicians involvement in clinical trials/research increasingly common • In Malaysia all clinical investigators required to undergo (AND pass) Good Clinical Practice (GCP) course • To ensure that investigator/s can conduct GCP compliant studies • See slides.

  4. IRB/IEC • Institutional Review Board (IRB)/Independent Ethics Committee (IEC) • Responsibilities • Composition, Functions and Operations • Procedures • Records

  5. Investigator • Investigator's Qualifications and Agreements • Adequate Resources • Medical Care of Trial Subjects • Communication with IRB/IEC • Compliance with Protocol • Investigational Product(s) • Randomization Procedures and Unblinding • Informed Consent of Trial Subjects • Records and Reports • Progress Reports • Safety Reporting • Premature Termination or Suspension of a Trial • Final Report(s) by Investigator

  6. Sponsor • Quality Assurance and Quality Control • Contract Research Organization (CRO) • Medical Expertise • Trial Design • Trial Management, Data Handling, and Record Keeping • Investigator Selection • Allocation of Responsibilities • Compensation to Subjects and Investigators • Financing • Notification/Submission to Regulatory Authority/ies • Confirmation of Review by IRB/IEC • Information on Investigational Product(s) • Manufacturing, Packaging, Labelling, and Coding Investigational Product(s) • Supplying and Handling Investigational Product(s) • Record Access • Safety Information • Adverse Drug Reaction Reporting • Monitoring • Audit • Noncompliance • Premature Termination of a Trial • Clinical Trial/Study Reports • Multicentre Trials

  7. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S) • Background Information • Trial Objectives and Purpose • Trial Design • Selection and Withdrawal of Subjects • Treatment of Subjects • Assessment of Efficacy • Assessment of Safety • Statistics • Direct Access to Source Data/Documents • Quality Control and Quality Assurance Procedures • Ethics • Data Handling and Record Keeping • Financing and Insurance • Publication Policy

  8. INVESTIGATOR’S BROCHURE • Title Page • Confidentiality Statement • Contents of the Investigator’s Brochure • Table of Contents • Summary • Introduction • Physical, Chemical, and Pharmaceutical Properties and Formulation • Nonclinical Studies • Effects in Humans • Summary of Data and Guidance for the Investigator

  9. ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICALTRIAL • Introduction • Before the Clinical Phase of the Trial Commences • During the Clinical Conduct of the Trial • After Completion or Termination of the Trial

  10. Conclusion • Compliance to GCP guidelines is essential when generating clinical trial data for submission to regulatory authorities • The principles established may also be applied to other clinical investigations that may have an impact on safety and well-being of human subjects Shukran!

More Related